Gam Holding Ag Vertex Pharmaceuticals Inc Transaction History

Gam Holding Ag

$1.22 Billion
Q2 2024

A detailed history of Gam Holding Ag transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Gam Holding Ag holds 8,910 shares of VRTX stock, worth $4.12 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

8,910

Previous 10,316 13.63%

Holding current value

$4.12 Million

Previous $4.31 Million 3.15%

% of portfolio

0.34%

Previous 0.33%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	SELL	$392.81 - $485.53 $552,290 - $682,655	-1,406 Reduced 13.63%	8,910 $4.18 Million
Q1 2024 May 13, 2024	BUY	$407.69 - $446.08 $4,076 - $4,460	10 Added 0.1%	10,316 $4.31 Million
Q4 2023 Jan 23, 2024	BUY	$343.0 - $410.68 $1.02 Million - $1.22 Million	2,979 Added 40.66%	10,306 $4.19 Million
Q3 2023 Oct 16, 2023	BUY	$338.18 - $362.46 $676 - $724	2 Added 0.03%	7,327 $2.55 Million
Q2 2023 Jul 27, 2023	SELL	$314.42 - $351.91 $3,773 - $4,222	-12 Reduced 0.16%	7,325 $2.58 Million
Q1 2023 May 09, 2023	BUY	$283.23 - $323.1 $121,222 - $138,286	428 Added 6.19%	7,337 $2.31 Million
Q4 2022 Feb 02, 2023	BUY	$285.76 - $321.48 $1.97 Million - $2.22 Million	6,909 New	6,909 $2 Million
Q1 2022 May 06, 2022	SELL	$221.42 - $260.97 $221 - $260	-1 Reduced 0.02%	6,160 $1.61 Million
Q4 2021 Jan 26, 2022	SELL	$177.01 - $223.45 $190,108 - $239,985	-1,074 Reduced 14.84%	6,161 $1.35 Million
Q3 2021 Nov 12, 2021	BUY	$181.39 - $202.99 $181 - $202	1 Added 0.01%	7,235 $1.31 Million
Q2 2021 Aug 09, 2021	SELL	$187.49 - $221.1 $456,913 - $538,820	-2,437 Reduced 25.2%	7,234 $1.46 Million
Q1 2021 May 10, 2021	BUY	$207.02 - $241.31 $2 Million - $2.33 Million	9,671 New	9,671 $2.08 Million
Q4 2020 Feb 10, 2021	SELL	$207.01 - $276.09 $4.54 Million - $6.05 Million	-21,922 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$255.65 - $303.1 $7,413 - $8,789	29 Added 0.13%	21,922 $5.97 Million
Q2 2020 Aug 10, 2020	SELL	$225.48 - $295.8 $85,907 - $112,699	-381 Reduced 1.71%	21,893 $6.36 Million
Q1 2020 May 12, 2020	SELL	$199.77 - $247.81 $104,679 - $129,852	-524 Reduced 2.3%	22,274 $5.3 Million
Q4 2019 Feb 06, 2020	SELL	$166.71 - $223.91 $5,834 - $7,836	-35 Reduced 0.15%	22,798 $4.99 Million
Q3 2019 Nov 08, 2019	SELL	$166.23 - $187.09 $14,129 - $15,902	-85 Reduced 0.37%	22,833 $3.87 Million
Q2 2019 Aug 12, 2019	BUY	$164.61 - $190.37 $15,802 - $18,275	96 Added 0.42%	22,918 $4.2 Million
Q1 2019 May 10, 2019	BUY	$163.73 - $194.7 $2.16 Million - $2.57 Million	13,219 Added 137.65%	22,822 $4.2 Million
Q4 2018 Feb 08, 2019	SELL	$151.91 - $192.21 $167,101 - $211,431	-1,100 Reduced 10.28%	9,603 $1.59 Million
Q3 2018 Nov 13, 2018	BUY	$167.73 - $192.74 $688,196 - $790,812	4,103 Added 62.17%	10,703 $2.06 Million
Q1 2018 May 15, 2018	SELL	$151.6 - $177.13 $1.26 Million - $1.47 Million	-8,300 Reduced 55.7%	6,600 $1.08 Million
Q4 2017 Feb 14, 2018	BUY	$137.28 - $155.55 $2.05 Million - $2.32 Million	14,900 New	14,900 $2.23 Million
Q3 2017 Nov 14, 2017	SELL	$148.13 - $162.24 $3.49 Million - $3.82 Million	-23,537 Closed	0 $0
Q2 2017 Aug 07, 2017	BUY	N/A	23,537	23,537 $3.03 Million

Others Institutions Holding VRTX

# of Institutions

1,708

Shares Held

226M

Call Options Held

1.2M

Put Options Held

1.59M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gam Holding Ag, based on Form 13F filings with the SEC.

News

Stay updated on Gam Holding Ag with notifications on news.

Account